Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
3.510
+0.240 (7.34%)
Aug 15, 2025, 4:00 PM - Market closed
Skye Bioscience Employees
Skye Bioscience had 16 employees as of December 31, 2024. The number of employees increased by 5 or 45.45% compared to the previous year.
Employees
16
Change (1Y)
5
Growth (1Y)
45.45%
Revenue / Employee
n/a
Profits / Employee
-$2,648,310
Market Cap
108.77M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16 | 5 | 45.45% |
Dec 31, 2023 | 11 | 0 | - |
Dec 31, 2022 | 11 | 2 | 22.22% |
Dec 31, 2021 | 9 | 3 | 50.00% |
Dec 31, 2020 | 6 | 2 | 50.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SKYE News
- 9 days ago - Skye Bioscience, Inc. (SKYE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update - GlobeNewsWire
- 17 days ago - Skye Bioscience to Announce Second Quarter 2025 Financial Results and Business Update on August 7, 2025 - GlobeNewsWire
- 5 weeks ago - Skye Bioscience Partners With Arecor: Potentially Enhanced Nimacimab Dosing - Seeking Alpha
- 7 weeks ago - Skye Bioscience Shares Nimacimab “Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association's 85th Scientific Sessions - GlobeNewsWire
- 2 months ago - Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association's 85th Scientific Sessions - GlobeNewsWire
- 3 months ago - Skye Bioscience to Participate in Upcoming Investment Conferences - GlobeNewsWire
- 3 months ago - Skye Bioscience Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab - GlobeNewsWire